The global e-learning market is projected to grow from $275.9 billion in 2026 to $506.6 billion by 2032, with a CAGR of 10.62% driven by rising internet connectivity, corporate upskilling demands, and government digital education initiatives. North America leads with the largest market share, while Asia-Pacific shows strong growth potential. Challenges remain in learner engagement and digital infrastructure in rural areas. The market expansion is supported by flexible, cost-effective training solutions and increasing adoption of learning management systems across academic and corporate sectors.
The e-learning industry outlook offers a context for technology sector performance on Pluang. For readers following technology stocks, here is Pluang's market snapshot as of Nov 05, 2026 02:01 WIB: Among 150 priced US technology stocks, 77 rose and 73 fell today. Notable movers include DDOG at USD 187.58 with a 1-day change of -14.94% and a typical hold time of 77 days, CDW at USD 169.48 up 13.16% with a 60-day hold time, and LYFT at USD 18.72 up 12.30% with a 48-day hold time.
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
Ontex disclosed that Goldman Sachs Group, Inc. crossed the 3% ownership threshold in Ontex shares on October 27, 2026, holding a combined total of 3.07% including voting rights and financial instruments. However, the next day, October 28, 2026, Goldm...
Neion Bio has appointed John A. Maga, Ph.D., as Head of Biologics and CMC to lead the development of biologic medicines using its Raptor platform, which produces proteins in transgenic chicken eggs. Maga brings over 25 years of biopharmaceutical expe...
The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...
